“…The reduction in CR-BSI rates using lock solution has been evidenced in various trials and meta-analyses published recently, yet the best prophylactic lock therapy option is still the subject of study (Silva et al, 2012;Filiopoulos et al, 2011;Weijmer et al, 2005;Zwiech et al, 2016;Solomon et al, 2010;Murray et al, 2014;Takla et al, 2007;Vercaigne et al, 2016;Maki et al, 2011;Dogra et al, 2002;Kim et al, 2006;Nori et al, 2006; Al-Hwiesh and -Rahman, 2007;Campos et al, 2011;Moran et al, 2012;Moore et al, 2014;Hemmelgarn et al, 2011;Wasse, 2008). In this study, the use of prophylactic lock therapy was studied only in catheters tunneled for HD, with a follow-up of at least 6 months, comparing solutions containing antibiotics (gentamicin + cefazolin) versus antimicrobial solutions (taurolidine + citrate); these solutions presented similar results in reducing CR-BSI and ESI.…”